Ad

MPH – Medicure Inc

Compliant

★★★★★

Medicure Inc is Shariah compliant. The company passes all five major Shariah standards.

$9,603,853

Market cap

52.99%

Revenue Growth

-

Analysts' Rating

Ad
N/A

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Medicure Inc. is a Canada-based pharmaceutical company, which is focused on the development and commercialization of therapies for the United States cardiovascular market. The Company is focused on the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an extended supply drug program serving all 50 states, Washington D.C., and Puerto Rico. AGGRASTAT is a glycoprotein inhibitor (GPI), used for the treatment of non-ST elevation acute coronary syndrome (NSTE-ACS), including unstable angina (UA), which is characterized by chest pain when one is at rest, and non-Q-wave myocardial infarction (MI). ZYPITAMAG is used for the treatment of patients with primary hyperlipidemia or mixed dyslipidemia.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses